<DOC>
	<DOCNO>NCT00195689</DOCNO>
	<brief_summary>The purpose study ass long-term safety clinical efficacy adalimumab treatment moderate severely active psoriatic arthritis</brief_summary>
	<brief_title>Safety Efficacy Adalimumab Patients With Moderate Severely Active Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject complete study M02518 M02570 Subject prematurely discontinue study M02518 M02570 Female subject pregnant breastfeeding consider become pregnant Subject consider investigator , reason , unsuitable candidate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>